(EMAILWIRE.COM, June 12, 2018 ) Singapore,
A global report titled Acute Ischemic Stroke Therapeutics Market has been introduced into our library of 2.5 million reports.
About the market report:
AIS is a chronic condition characterized by the sudden loss of blood supply to a part of the brain, thus causing subsequent loss of neurological function. AIS is caused by thrombotic or embolic obstruction of the cerebral artery and is more common than hemorrhagic stroke. The global AIS therapeutics market is expected to register a low single digit market growth during the forecast period. The marginal growth rate is attributed to the lack of approved drugs in this area, the presence of alternative therapies, extensive use of generics, and unmet needs for anticoagulant reversal agents. Analysts forecast the global acute ischemic stroke therapeutics market to grow at a CAGR of 2.11% during the period 2017-2021.

To access the full table of contents of the report click below: https://www.marketintelreports.com/report/tech0256/global-acute-ischemic-stroke-therapeutics-market-20172021

Covered in this report
The report covers the present scenario and the growth prospects of the global Acute Ischemic Stroke Therapeutics market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography: 
• Americas
• APAC
• EMEA

Global Acute Ischemic Stroke Therapeutics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.


Key vendors
• Bayer
• Boehringer Ingelheim
• F. Hoffmann-La Roche
• Sanofi
Other prominent vendors
• Biogen
• Daiichi Sankyo
• Pfizer

There are 15 Chapters to deeply display the global Acute Ischemic Stroke Therapeutics market.

To find out more of the report or request some customization: https://www.marketintelreports.com/inquiry-before-buying.php?id=tech0256

Table of Contents-Key Points Covered
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
• Market outline
PART 05: Acute ischemic stroke (AIS): An overview
• Ischemia
• IHD
• Stroke
• AIS
PART 06: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 07: Pipeline landscape
PART 08: Market segmentation by drug-class
• Thrombolytic therapeutics
• Antihypertensive therapeutics
• Antiplatelet therapeutics
• Anticoagulants
• Others
PART 09: Geographical segmentation
• Market overview based on geography
• AIS therapeutics market in Americas
• AIS therapeutics market in EMEA
• AIS therapeutics market in APAC
PART 10: Decision framework
Continued…..
Complete Report Details @ https://www.marketintelreports.com/report/tech0256/global-acute-ischemic-stroke-therapeutics-market-20172021

About us:
MIR intends to be a one-stop shop with an intuitive design, exhaustive database, expert assistance, secure cart checkout and data privacy integrated. It curates the list of reports, publishers and studies to ensure that the database is constantly updated to dynamically meet the targeted, specific needs of our clients.
MarketIntelReports currently has more than 2.5 million titles and 200 publishers on our platform and are growing consistently to fill the “World Intelligence Demand – Supply Gap”. We cover more than 15 industry verticals being: Automotive, Electronics, Manufacturing, Pharmaceuticals, Healthcare, Chemicals, Building & Construction, Agriculture, Food & Beverages, Banking & Finance, Media and Government, Public Sector Studies.

Contact Information:
MarketIntelReports
Lakshmi
Tel: 1-302-261-5343
Email us


----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results